Improving Glycemic Control on GMS: A Quality Improvement Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Diabetes Mellitus
- Sponsor
- Brigham and Women's Hospital
- Enrollment
- 179
- Locations
- 1
- Primary Endpoint
- - Point-of-care testing glucose values (percent of routine glucose readings between 60 and 180 mg/dL)
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
This study will examine whether new processes and technologies for monitoring diabetic patients' insulin levels improves patient care at Brigham and Women's Hospital.
Detailed Description
This study will examine whether new processed and technologies for monitoring diabetic patients' insulin levels improves patient care. Patients at Brigham and Women's Hospital (BWH), staying on the General Medicine Service, who have Type 2 diabetes and who are not on IV insulin can participate in this study. Physicians and nurses will be taught new rules to care for diabetic patients, while in the hospital. Also, the BWH computer system will be updated to include these new rules for administering insulin. Patients who participate in the study will be randomly placed into one of two groups: one group that will be cared for by physicians and nurses who have learned these new rules for administering insulin; or the second group, who will receive diabetes care at BWH before the new rules were adopted. The study will last approximately 1 year.
Investigators
Jeffrey L. Schnipper, MD.,MPH.
Jeffrey Schnipper, MD
Brigham and Women's Hospital
Eligibility Criteria
Inclusion Criteria
- •Subjects will include all type 2 diabetic patients on the General Medicine Service (GMS) of Brigham and Women's Hospital (BWH) who do not have an indication for IV insulin.
Exclusion Criteria
- •Type 2 diabetic patients on the General Medicine Service (GMS) of Brigham and Women's Hospital (BWH) who have an indication for IV insulin.
Outcomes
Primary Outcomes
- Point-of-care testing glucose values (percent of routine glucose readings between 60 and 180 mg/dL)
- Lab glucose values (percent of routine glucose readings between 60 and 180 mg/dL)
Secondary Outcomes
- - Quality of insulin orders using explicit criteria